Suppr超能文献

长骨造釉细胞瘤:11例长期随访研究

Adamantinoma of long bones: a long-term follow-up study of 11 cases.

作者信息

Szendroi Miklós, Antal Imre, Arató Gabriella

机构信息

Department of Orthopedics, Semmelweis University, 27 Karolina Rd., Budapest 1113, Hungary.

出版信息

Pathol Oncol Res. 2009 Jun;15(2):209-16. doi: 10.1007/s12253-008-9125-x. Epub 2008 Dec 2.

Abstract

The aim of this study was to evaluate the clinicopathological features and prognostic significances of 11 histologically proven adamantinoma cases based on an average 12,7 year long follow-up. The male: female ratio was 8:3, aged between 4 and 80 years (mean 29,3 years). The initial diagnosis at referral was other than adamantinoma in six patients (fibrous dysplasia, carcinoma metastasis, osteofibrous dysplasia, bone cyst, non-ossifying fibroma), referring to the differential diagnostic problems. All tumors were localized to the mid part of tibia. By histological evaluation, basaloid pattern on a background of fibrotic stroma dominated in six patients, while spindle and squamous features were less frequently seen. All adamantinoma were positive for cytokeratins often in coexpression with vimentin. No correlation was experienced between histology and clinical outcome. Intralesional curettage (2 pts) was followed by recurrence of the tumor. Wide resection was performed in eight patients with reconstruction using intercalary fibula autografts in seven patients. Reconstruction-related complications occurred in two third of the cases, all of them could however be controlled by repeated surgery. Six recurrences occurred in four patients, two of these recurrences occurred 20 and 16 years after initial surgery. One patient died 9 years after recognition of the tumor of pulmonary metastases. Adamantinoma of the long bones is a low grade malignant tumor, which clinical outcome is difficult to predict based on histology or surgical stage of the tumor. Wide surgical margin, e.g. resection the tumor reduces the rate of recurrence. This study underlines that recurrences do occur even decades after recognition the tumor, therefore a life-long follow-up of the patient is necessary.

摘要

本研究旨在基于平均12.7年的长期随访,评估11例经组织学证实的造釉细胞瘤病例的临床病理特征及预后意义。男女比例为8:3,年龄在4至80岁之间(平均29.3岁)。6例患者转诊时的初始诊断并非造釉细胞瘤(纤维发育不良、癌转移、骨纤维结构不良、骨囊肿、非骨化性纤维瘤),这提示了鉴别诊断问题。所有肿瘤均位于胫骨中部。通过组织学评估,6例患者以纤维化基质为背景的基底样模式为主,而梭形和鳞状特征较少见。所有造釉细胞瘤的细胞角蛋白均呈阳性,常与波形蛋白共表达。组织学与临床结果之间无相关性。2例患者采用病灶内刮除术,术后肿瘤复发。8例患者进行了广泛切除,其中7例患者使用腓骨中间段自体骨移植进行重建。三分之二的病例出现了与重建相关的并发症,但所有这些并发症均可通过再次手术得到控制。4例患者出现6次复发,其中2次复发分别发生在初次手术后20年和16年。1例患者在确诊肿瘤9年后死于肺转移。长骨造釉细胞瘤是一种低级别恶性肿瘤,其临床结果难以根据肿瘤的组织学或手术分期来预测。广泛的手术切缘,如切除肿瘤,可降低复发率。本研究强调,即使在确诊肿瘤数十年后仍会出现复发,因此对患者进行终身随访是必要的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验